Hausman Diana is a director of Immuneering Corp - Ordinary Shares.
Person profile
Roles
Address
Seattle, Washington
Employees
Former names
Hausman Diane
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
144
Zentalis Pharmaceuticals, Inc.
9 May 24
4
Zentalis Pharmaceuticals, Inc.
9 May 24
4
Zentalis Pharmaceuticals, Inc.
5 Feb 24
4
Immuneering Corp
15 Jun 23
4
Zentalis Pharmaceuticals, Inc.
10 May 23
3
Zentalis Pharmaceuticals, Inc.
10 May 23
4
Immuneering Corp
23 Jun 22
4
Immuneering Corp
18 Jan 22
3
Immuneering Corp
18 Jan 22
4
Zymeworks Inc.
12 Mar 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 May 24 | ZNTL Zentalis Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 12.62 | 3,356 | 42.35 k | 373,876 |
1 Feb 24 | ZNTL Zentalis Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 337,500 | 0.00 | 377,232 |
1 Feb 24 | ZNTL Zentalis Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 11.69 | 337,500 | 3.95 mm | 337,500 |
14 Jun 23 | IMRX Immuneering Corp - Ordinary Shares | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 9.32 | 17,500 | 163.10 k | 17,500 |
8 May 23 | ZNTL Zentalis Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 39,732 | 0.00 | 39,732 |